Agreed.
I am not attributing blame but this is very frustrating. I am worried that possible/likely changes to the head of Healthcare in the US may also impact these timelines - there may be a desire to stop and take a look under the hood, if DOGE is anything to go by.
- Forums
- ASX - By Stock
- NEU
- Ann: Type C Meeting granted by FDA for Phelan-McDermid syndrome
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.47%
!
$12.44

Ann: Type C Meeting granted by FDA for Phelan-McDermid syndrome, page-11
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.44 |
Change
0.180(1.47%) |
Mkt cap ! $1.542B |
Open | High | Low | Value | Volume |
$12.52 | $12.60 | $12.26 | $2.738M | 220.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 222 | $12.43 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.45 | 595 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 148 | 12.450 |
14 | 3319 | 12.440 |
5 | 1355 | 12.430 |
7 | 1509 | 12.420 |
6 | 1529 | 12.410 |
Price($) | Vol. | No. |
---|---|---|
12.480 | 442 | 4 |
12.490 | 553 | 3 |
12.500 | 1364 | 5 |
12.510 | 1340 | 4 |
12.520 | 1651 | 6 |
Last trade - 12.51pm 24/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |